International Regulators Explain Work-Sharing Scheme For Biosimilars

Follows Pilot Launched Earlier This Year

 
• By Vibha Sharma

New guidance from the ACCESS Consortium of regulators from five countries explains how biosimilar drug sponsors can apply for an internationally-coordinated review of new products.

Businessman handshake on mou - memorandum of understanding with legal document contract papers after agreement.
The Access Consortium relies on confidentiality agreements and memoranda of understanding to coordinate reviews • Source: Alamy

More from Biosimilars

More from Products